If you need more lookups,
subscriptions start at $34 USD/month.
Stephan Meier Location
Frenchs Forest, NSW, AU
Stephan Meier Work
2025 -now Senior Medical Advisor (Rare Diseases) @
2024 -2025 Therapeutic Area Head, Oncology @
2021 -2024 Senior Medical Manager @
2021 -2021 Experienced Medical Advisor - good dad and husband open for new challenges @ Selbstständig
2016 -2020 Senior Clinical Research Scientist @ Eli Lilly Australia Pty Ltd / Eli Lilly and Company (NZ) Limited
2015 -2016 Clinical Research Scientist (Oncology, Solid Tumors) @ Eli Lilly Australia Pty Ltd / Eli Lilly and Company (NZ) Limited
2012 -2015 Clinical Research Medical Advisor (Neuroscience and Primary Care) @
2011 -2012 Clinical Trial Head (Oncology, Heamatology) @
2008 -2011 Expert Clinical Manager (Oncology) @
2005 -2007 Clinical Project Manager @
Stephan Meier Education
Ludwig-Maximilians-Universität München
Dr. rer. nat. (Biochemistry)
2000-2005
University of Tübingen
Diplom (Biochemistry)
1993-1999
Stephan Meier Skills
Project Management
Clinical Trials
Clinical Development
Oncology
CRO
Pharmacovigilance
GCP
Translational Medicine
EDC
Clinical Data Management
Clinical Pharmacology
Pharmacodynamics
Regulatory Submissions
Pharmaceutical Industry
Pharmacokinetics
Regulatory Affairs
Pharmacology
Drug Discovery
Arzneimittelentwicklung
Klinische Forschung
Pharmaindustrie
Klinische Studien
Klinische Entwicklung
Gute klinische Praxis
Stephan Meier Summary
Stephan Meier, based in Frenchs Forest, NSW, AU, is currently a Senior Medical Advisor (Rare Diseases) at Novo Nordisk. Stephan Meier brings experience from previous roles at Astellas Pharma, Selbstständig and Eli Lilly Australia Pty Ltd / Eli Lilly and Company (NZ) Limited. Stephan Meier holds a 2000 - 2005 Dr. rer. nat. in Biochemistry @ Ludwig-Maximilians-Universität München. With a robust skill set that includes Project Management, Clinical Trials, Clinical Development, Oncology, CRO and more. Stephan Meier has 3 emails on RocketReach.
Looking for a different Stephan Meier?
Find contact details for 700 million professionals.